151 related articles for article (PubMed ID: 18006171)
1. Clinical significance of the metabolic syndrome in the absence of established hypertension and diabetes: A community-based study.
Hsu PF; Chuang SY; Cheng HM; Tsai ST; Chou P; Chen CH
Diabetes Res Clin Pract; 2008 Mar; 79(3):461-7. PubMed ID: 18006171
[TBL] [Abstract][Full Text] [Related]
2. Younger age of escalation of cardiovascular risk factors in Asian Indian subjects.
Gupta R; Misra A; Vikram NK; Kondal D; Gupta SS; Agrawal A; Pandey RM
BMC Cardiovasc Disord; 2009 Jul; 9():28. PubMed ID: 19575817
[TBL] [Abstract][Full Text] [Related]
3. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
[TBL] [Abstract][Full Text] [Related]
4. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome, clustering of cardiovascular risk factors and high carotid intima-media thickness in children and adolescents.
Zhao M; Caserta CA; Medeiros CCM; López-Bermejo A; Kollias A; Zhang Q; Pacifico L; Reinehr T; Litwin M; Bassols J; Romeo EL; Ramos TDA; Stergiou GS; Yang L; Xargay-Torrent S; Amante A; Estrela TM; Grammatikos E; Zhang Y; Prats-Puig A; Franklin de Carvalho D; Yang L; Carreras-Badosa G; de Oliveira Simões M; Hou Y; Lizarraga-Mollinedo E; Shui W; Guo T; Wang M; Zhang Y; Bovet P; Xi B;
J Hypertens; 2020 Apr; 38(4):618-624. PubMed ID: 31790055
[TBL] [Abstract][Full Text] [Related]
6. The metabolic syndrome increased risk of cardiovascular events in Chinese--a community based study.
Wang C; Hou X; Bao Y; Pan J; Zuo Y; Zhong W; Jia W; Xiang K
Int J Cardiol; 2010 Mar; 139(2):159-65. PubMed ID: 19046783
[TBL] [Abstract][Full Text] [Related]
7. Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study.
Lee IT; Chiu YF; Hwu CM; He CT; Chiang FT; Lin YC; Assimes T; Curb JD; Sheu WH
Cardiovasc Diabetol; 2012 Apr; 11():43. PubMed ID: 22537054
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.
McNeill AM; Katz R; Girman CJ; Rosamond WD; Wagenknecht LE; Barzilay JI; Tracy RP; Savage PJ; Jackson SA
J Am Geriatr Soc; 2006 Sep; 54(9):1317-24. PubMed ID: 16970637
[TBL] [Abstract][Full Text] [Related]
9. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
[TBL] [Abstract][Full Text] [Related]
10. Uric acid and risk of new-onset metabolic syndrome, impaired fasting glucose and diabetes mellitus in a general Italian population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study.
Bombelli M; Quarti-Trevano F; Tadic M; Facchetti R; Cuspidi C; Mancia G; Grassi G
J Hypertens; 2018 Jul; 36(7):1492-1498. PubMed ID: 29543626
[TBL] [Abstract][Full Text] [Related]
11. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome components and age-related cataract: the Singapore Malay eye study.
Sabanayagam C; Wang JJ; Mitchell P; Tan AG; Tai ES; Aung T; Saw SM; Wong TY
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2397-404. PubMed ID: 21228391
[TBL] [Abstract][Full Text] [Related]
13. Association between metabolic syndrome and carotid atherosclerosis in individuals without diabetes based on the oral glucose tolerance test.
Ishizaka N; Ishizaka Y; Yamakado M; Toda E; Koike K; Nagai R
Atherosclerosis; 2009 Jun; 204(2):619-23. PubMed ID: 19056083
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and risk of mortality in middle-aged versus elderly individuals: the Nord-Trøndelag Health Study (HUNT).
Hildrum B; Mykletun A; Dahl AA; Midthjell K
Diabetologia; 2009 Apr; 52(4):583-90. PubMed ID: 19194692
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
Meis SB; Schuster D; Gaillard T; Osei K
Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein.
Malik S; Wong ND; Franklin S; Pio J; Fairchild C; Chen R
Diabetes Care; 2005 Mar; 28(3):690-3. PubMed ID: 15735209
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of cardiometabolic risk factors and demographic role among Chinese elderly aged over 60 years in fifteen provinces (autonomous regions, municipalities) in 2015].
Wang L; Zhang B; Wang H; Zhang J; Du W; Jiang H; Wang Z
Wei Sheng Yan Jiu; 2019 Mar; 48(2):173-178. PubMed ID: 31133091
[TBL] [Abstract][Full Text] [Related]
18. The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.
Bonora E; Targher G; Formentini G; Calcaterra F; Lombardi S; Marini F; Zenari L; Saggiani F; Poli M; Perbellini S; Raffaelli A; Gemma L; Santi L; Bonadonna RC; Muggeo M
Diabet Med; 2004 Jan; 21(1):52-8. PubMed ID: 14706054
[TBL] [Abstract][Full Text] [Related]
19. Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study.
Li YW; Kao TW; Chang PK; Chen WL; Wu LW
Sci Rep; 2021 May; 11(1):9900. PubMed ID: 33972652
[TBL] [Abstract][Full Text] [Related]
20. Predictors of the incident metabolic syndrome in healthy obese subjects: a decade of follow-up from the Tehran Lipid and Glucose Study.
Hosseinpanah F; Nazeri P; Ghareh S; Tohidi M; Azizi F
Eur J Clin Nutr; 2014 Mar; 68(3):295-9. PubMed ID: 23963276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
